U.S. markets open in 7 hours 13 minutes
  • S&P Futures

    4,066.75
    +8.00 (+0.20%)
     
  • Dow Futures

    33,535.00
    +27.00 (+0.08%)
     
  • Nasdaq Futures

    13,044.75
    +46.25 (+0.36%)
     
  • Russell 2000 Futures

    2,136.90
    +5.40 (+0.25%)
     
  • Crude Oil

    65.22
    -0.86 (-1.30%)
     
  • Gold

    1,818.80
    -4.00 (-0.22%)
     
  • Silver

    27.06
    -0.19 (-0.69%)
     
  • EUR/USD

    1.2089
    +0.0013 (+0.11%)
     
  • 10-Yr Bond

    1.6950
    0.0000 (0.00%)
     
  • Vix

    27.59
    +5.75 (+26.33%)
     
  • GBP/USD

    1.4050
    -0.0007 (-0.05%)
     
  • USD/JPY

    109.6500
    -0.0100 (-0.01%)
     
  • BTC-USD

    51,034.32
    -6,187.65 (-10.81%)
     
  • CMC Crypto 200

    1,399.56
    -164.27 (-10.50%)
     
  • FTSE 100

    7,004.63
    +56.64 (+0.82%)
     
  • Nikkei 225

    27,436.42
    -711.09 (-2.53%)
     

What Type Of Shareholders Own The Most Number of Starpharma Holdings Limited (ASX:SPL) Shares?

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Simply Wall St
·4 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

A look at the shareholders of Starpharma Holdings Limited (ASX:SPL) can tell us which group is most powerful. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a noticeable percentage of the smaller ones. Companies that used to be publicly owned tend to have lower insider ownership.

With a market capitalization of AU$443m, Starpharma Holdings is a small cap stock, so it might not be well known by many institutional investors. Taking a look at our data on the ownership groups (below), it's seems that institutions own shares in the company. Let's take a closer look to see what the different types of shareholder can tell us about Starpharma Holdings.

See our latest analysis for Starpharma Holdings

ownership-breakdown
ownership-breakdown

What Does The Institutional Ownership Tell Us About Starpharma Holdings?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

We can see that Starpharma Holdings does have institutional investors; and they hold a good portion of the company's stock. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Starpharma Holdings's historic earnings and revenue, below, but keep in mind there's always more to the story.

earnings-and-revenue-growth
earnings-and-revenue-growth

We note that hedge funds don't have a meaningful investment in Starpharma Holdings. Our data shows that Orbis Investment Management Limited is the largest shareholder with 14% of shares outstanding. In comparison, the second and third largest shareholders hold about 12% and 5.1% of the stock. Additionally, the company's CEO Jacinth Fairley directly holds 0.0104826 of the total shares outstanding.

A closer look at our ownership figures suggests that the top 12 shareholders have a combined ownership of 51% implying that no one share holder has a majority.

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There is a little analyst coverage of the stock, but not much. So there is room for it to gain more coverage.

Insider Ownership Of Starpharma Holdings

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

We can see that insiders own shares in Starpharma Holdings Limited. It has a market capitalization of just AU$443m, and insiders have AU$20m worth of shares, in their own names. Some would say this shows alignment of interests between shareholders and the board. But it might be worth checking if those insiders have been selling.

General Public Ownership

With a 44% ownership, the general public have some degree of sway over SPL. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.

Next Steps:

While it is well worth considering the different groups that own a company, there are other factors that are even more important.

I always like to check for a history of revenue growth. You can too, by accessing this free chart of historic revenue and earnings in this detailed graph.

If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.